Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2024-10-07 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
AstraZeneca licenses lipid lowering Lp(a) asset
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and is dated '07 October 2024'. It announces a specific corporate event: an exclusive license agreement between AstraZeneca and CSPC for a novel therapy. This type of announcement, detailing a strategic business development (licensing/M&A related activity) released via the RNS system and approved by the FCA, fits best under the general 'Regulatory Filings' category, as it is not a standard financial report (10-K, IR, ER) or a specific corporate action like a dividend or share buyback. While it relates to pipeline development, it is primarily a material corporate disclosure disseminated through the regulatory news service.
2024-10-07 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2024-10-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official notification released via RNS (London Stock Exchange news service) under the Transparency Directive. It explicitly states the total number of voting rights and the issued share capital as of a specific date (30 September 2024). This type of regulatory disclosure concerning the total number of voting rights, which shareholders use as a denominator for disclosure calculations, is a specific type of regulatory announcement. While it relates to capital structure, it is not a financing activity (CAP) or a share issue (SHA), but rather a mandatory disclosure under transparency rules. Since it is a general regulatory announcement provided via RNS that doesn't fit perfectly into the other specific categories (like DIRS, DIV, or MRQ), the most appropriate classification is the general regulatory filing category, RNS.
2024-10-01 English
TAGRISSO US APPROVAL IN UNRESECTABLE LUNG CANCER
Foreign Filer Report
2024-09-26 English
Tagrisso US approval in unresectable lung cancer
Regulatory Filings Classification · 1% confidence The document begins with 'National Storage Mechanism' and prominently features 'RNS Number : 7112F' and the date '26 September 2024'. The content is a press release announcing a regulatory event: the FDA approval of Tagrisso for a specific cancer indication, based on clinical trial results. The closing section explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and explicit mention of RNS strongly indicate a general regulatory announcement rather than a specific financial report (like 10-K, IR, or ER). Since it is a formal announcement distributed via the RNS system that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing category.
2024-09-26 English
FASENRA RECOMMENDED FOR EU APPROVAL IN EGPA
Foreign Filer Report
2024-09-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.